Early Genetic Mechanisms Underlying the Inhibitory Effects of Endostatin and Fumagillin on Human Endothelial Cells
Open Access
- 2 August 2004
- journal article
- Published by Cold Spring Harbor Laboratory in Genome Research
- Vol. 14 (8) , 1585-1593
Abstract
A tumor needs to initiate angiogenesis in order to develop its own blood supply, to grow, to invade, and to spread. Angiogenesis, under normal conditions, is a tightly regulated balance between endogenous pro- and antiangiogenic factors. In this study, we investigated, by microarray analysis, the effects of two known antiangiogenic agents (endostatin and fumagillin) on the gene expression profiles of human umbilical vein endothelial cells (HUVEC) in order to elucidate pathways common to the effects of these agents. We observed a majority of gene expression changes within 1 and 2 h of treatment. The genes demonstrating these early expression changes are involved in cell proliferation, gene transcription, and a number have unknown functions. We selected four genes (DOC1, KLF4, TC-1, ID1) from the microarray profile that showed a similar pattern of expression for both of the antiangiogenic agents we tested. We then used small interfering RNAs (siRNA) in an attempt to better understand the role of these selected genes in the inhibitory activity of these agents. Because the gene expression changes occurred within 1 and 2 h of treatment, these genes might be involved in the initial pathways of angiogenesis inhibition.Keywords
This publication has 40 references indexed in Scilit:
- Endostatin action and intracellular signaling: β-catenin as a potential target?Cancer Letters, 2003
- Inhibition of angiogenesis at endothelial cell levelMicroscopy Research and Technique, 2002
- Clinical translation of angiogenesis inhibitorsNature Reviews Cancer, 2002
- The antitumoral effect of endostatin and angiostatin is associated with a down‐regulation of vascular endothelial growth factor expression in tumor cellsThe FASEB Journal, 2002
- Angiogenesis, views and news. The 93rd Annual Meeting of the American Association for Cancer ResearchExpert Opinion on Biological Therapy, 2002
- New functions for the matrix metalloproteinases in cancer progressionNature Reviews Cancer, 2002
- Cloning of TC-1 (C8orf4), a Novel Gene Found to Be Overexpressed in Thyroid CancerGenomics, 2000
- Selective inhibition of endothelial cell proliferation by fumagillin is not due to differential expression of methionine aminopeptidasesJournal of Cellular Biochemistry, 2000
- Systematic variation in gene expression patterns in human cancer cell linesNature Genetics, 2000
- Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growthNature, 1990